Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797004 · ClinicalTrials.gov registry record
Olfactory Dysfunction of Rhinosinusitis
A clinical trial, sponsored by Greg Davis.
- Completed
- Registry status
- 23
- Enrollment target
NCT00797004: Completed study, sponsored by Greg Davis.
NCT00797004 is a clinical trial that has completed, run by Greg Davis. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00797004 has completed, sponsored by Greg Davis.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this research is to improve understanding of the molecular and functional properties of the human olfactory system. The specific aims are: * to determine the location of AC3 and Golf proteins in the human olfactory epithelium from freshly harvested nasal/sinus tissue of surgical patients * to perform objective functional studies on fresh human nasal/sinus tissue using an electro-olfactogram (EOG) whic measures the electrical activity of olfactory sensory neurons in fresh biopsied tissue in response to odor or pheromone stimulation. An organotypic culture system for human tissue has been established to optimize the electrical signal acquisition. * to correlate the AC3 and Golf expression profiles with pre-operative testing of human olfactory function * to correlate the EOG findings with pre-operative testing of human olfactory function. * to systematically evaluate the role of individual intranasal agents on olfaction to further optimize the electrical signal acquisition from olfactory tissue.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-09 |
What the finished NCT00797004 record still lists
NCT00797004 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00797004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00797004 about?
NCT00797004 is a clinical study titled "Olfactory Dysfunction of Rhinosinusitis". The purpose of this research is to improve understanding of the molecular and functional properties of the human olfactory system. The specific aims are: * to determine the location of AC3 and Golf proteins in the human olfactory epithelium from freshly harvested nasal/sinus tissue of surgical pat...
What is the current status of trial NCT00797004?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2008-11. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00797004?
This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia